Dr. Andrew Kiberu, MBChB

Claim this profile

Fional Stanley Hospital

Studies Adenocarcinoma
Studies Stomach Tumors
1 reported clinical trial
5 drugs studied

Area of expertise

1Adenocarcinoma
Andrew Kiberu, MBChB has run 1 trial for Adenocarcinoma. Some of their research focus areas include:
Stage III
Stage IV
HER2 positive
2Stomach Tumors
Andrew Kiberu, MBChB has run 1 trial for Stomach Tumors. Some of their research focus areas include:
Stage III
Stage IV
HER2 positive

Clinical Trials Andrew Kiberu, MBChB is currently running

Image of trial facility.

Zanidatamab + Chemotherapy ± Tislelizumab

for Stomach and Esophageal Cancer

This trial is testing zanidatamab combined with chemotherapy, and sometimes with another drug called tislelizumab, to see if it works better than the current treatment. It targets patients with advanced HER2-positive stomach and esophageal cancers that can't be treated with surgery or standard treatments. The goal is to help the immune system find and destroy cancer cells more effectively. Zanidatamab is a novel HER2-targeting agent being evaluated for its efficacy in advanced HER2-positive cancers.
Recruiting2 awards Phase 3

More about Andrew Kiberu, MBChB

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Andrew Kiberu, MBChB has experience with
  • Cisplatin
  • Oxaliplatin
  • Tislelizumab
  • Trastuzumab
  • Zanidatamab
Breakdown of trials Andrew Kiberu, MBChB has run
Adenocarcinoma
Stomach Tumors
Esophageal Cancer
Gastric Neoplasm
Gastroesophageal Adenocarcinoma

Other Doctors you might be interested in

Amit B. ShahSechler Family Cancer Center
Michael O'Sullivan, Dr.Fiona Stanley Hospital
Lena ThinFiona Stanley Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Kiberu, MBChB specialize in?
Andrew Kiberu, MBChB focuses on Adenocarcinoma and Stomach Tumors. In particular, much of their work with Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Andrew Kiberu, MBChB currently recruiting for clinical trials?
Yes, Andrew Kiberu, MBChB is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Andrew Kiberu, MBChB has studied deeply?
Yes, Andrew Kiberu, MBChB has studied treatments such as Cisplatin, Oxaliplatin, Tislelizumab.
What is the best way to schedule an appointment with Andrew Kiberu, MBChB?
Apply for one of the trials that Andrew Kiberu, MBChB is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top